EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Antithrombotic Effects of Cordycepin-Enriched WIB-801CE via Inhibition of Thromboxane A2-Induced αIIbβ3 Activation and Thrombin-Mediated Fibrin Clot Retraction

Min-Kyu Park, Jeong-Soo Bae, Hyeonha Jang iD, Jae-Ho Shin iD, Hwa-Jin Park

International Journal of Molecular Sciences · 2026

DOI: 10.3390/ijms27052254 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2026. Verfasst von Min-Kyu Park und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Applied Biosciences, Kyungpook National University, Daegu 41566, Republic of Korea. Hauptthemen laut MEDLINE: Thromboxane A2, Thrombin, Clot Retraction, Platelet Glycoprotein GPIIb-IIIa Complex. Die Arbeit nennt 63 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Korea Basic Science Institute, Ministry of Education, Ministry of Climate, Energy and Environment.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

WIB-801CE, a standardized Cordyceps militaris extract containing 7.0% cordycepin, suppresses platelet activation induced by thrombin, collagen, and Adenosine diphosphate (ADP). As these agonists generate thromboxane A2 (TXA2), which amplifies platelet activation via a self-propagating feedback loop, blockade of TXA2-mediated signaling offers strong antithrombotic potential. TXA2-antagonistic effects were evaluated using U46619, a stable TXA2 analog. Platelet activation was assessed by fibrinogen binding to integrin αIIbβ3, aggregation, and phosphorylation of platelet-activating proteins—PI3K (Tyr458), Akt (Ser473), p38 MAPK (Thr180/Tyr182), ERK1 (Thr202/Tyr204), JNK1 (Thr183/Tyr185)—and inhibitory proteins—VASP (Ser157) and IP3RI (Ser1756)—via immunoblotting. Thrombin-induced fibrin clot retraction, cytotoxicity, coagulation parameters, and antioxidant capacity were also examined. WIB-801CE significantly inhibited U46619-induced fibrinogen binding to integrin αIIbβ3 and platelet aggregation, without inducing cytotoxicity or impairing hemostatic function. It also significantly downregulated the phosphorylation of platelet-activating proteins and upregulated the phosphorylation of platelet-inhibiting proteins. Additionally, WIB-801CE abolished thrombin-induced fibrin clot retraction and demonstrated antioxidant capacity. WIB-801CE disrupts TXA2-driven platelet activation and thrombus stabilization by selectively modulating phosphorylation of key signaling proteins at defined regulatory sites. These properties highlight its promise as a therapeutic candidate for thrombotic disorders with platelet hyperreactivity.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Thromboxane A2ThrombinClot RetractionPlatelet Glycoprotein GPIIb-IIIa ComplexFibrinolytic AgentsFibrinHumansPlatelet ActivationPhosphorylationPlatelet AggregationSignal TransductionBlood PlateletsFibrinogen

Stichwörter der Autor:innen

WIB-801CE (cordycepin)blood coagulationfibrin clot retractionfibrinogen binding to integrin αIIbβ3phosphoprotein phosphorylationplatelet activationthromboxane A2

Substanzen

Thromboxane A2ThrombinPlatelet Glycoprotein GPIIb-IIIa ComplexFibrinolytic AgentsFibrinFibrinogen

Autor:innen und Institutionen

  • Department of Applied Biosciences, Kyungpook National University, Daegu 41566, Republic of Korea.
  • KNU NGS Core Facility, Kyungpook National University, Daegu 41566, Republic of Korea.
  • Microbalance Inc., Daegu 41566, Republic of Korea.
  • Cardiovascular Laboratory, Medical Center of Dong-A University, 26 Daesingongwon-ro, Busan 49201, Republic of Korea.
  • College of Pharmacology, Kyungpook National University, Daegu 41566, Republic of Korea.
  • Department of Biomedical Laboratory Science, College of Healthcare Medical Science and Engineering, Inje University, 197, Inje-ro, Gimhae 50834, Republic of Korea.

ORCID-Profile: Hyeonha Jang, Jae-Ho Shin

Förderung

  • Korea Basic Science Institute
  • Ministry of Education
  • Ministry of Climate, Energy and Environment

Zitieren

APA

Park, M. K., Bae, J. S., Jang, H., Shin, J. H., & Park, H. J. (2026). Antithrombotic Effects of Cordycepin-Enriched WIB-801CE via Inhibition of Thromboxane A2-Induced αIIbβ3 Activation and Thrombin-Mediated Fibrin Clot Retraction. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms27052254

Vancouver

Park MK, Bae JS, Jang H, Shin JH, Park HJ. Antithrombotic Effects of Cordycepin-Enriched WIB-801CE via Inhibition of Thromboxane A2-Induced αIIbβ3 Activation and Thrombin-Mediated Fibrin Clot Retraction. International Journal of Molecular Sciences. 2026. doi:10.3390/ijms27052254

BibTeX
@article{Park2026,
  author = {Park, Min-Kyu and Bae, Jeong-Soo and Jang, Hyeonha and Shin, Jae-Ho and Park, Hwa-Jin},
  title = {Antithrombotic Effects of Cordycepin-Enriched WIB-801CE via Inhibition of Thromboxane A2-Induced αIIbβ3 Activation and Thrombin-Mediated Fibrin Clot Retraction},
  journal = {International Journal of Molecular Sciences},
  year = {2026},
  doi = {10.3390/ijms27052254}
}
Kostenlos starten →